SILO

SILO Pharma Inc

May 19 • 04:00PM ET

0.3730

-0.0147 -3.79 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: TNXP LIXT PALI BCDA SABS

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.50	Insider Own	1.69%	Shs Outstand	16.27M	Perf Week	-5.81%
Market Cap	6.07M	Forward P/E	-	EPS next Y	-	Insider Trans	7.42%	Shs Float	15.99M	Perf Month	-44.00%
Enterprise Value	-0.20M	PEG	-	EPS next Q	-	Inst Own	6.49%	Short Float	4.83%	Perf Quarter	27.30%
Income	-4.84M	P/S	86.73	EPS this Y	-	Inst Trans	-10.07%	Short Ratio	0.16	Perf Half Y	-9.73%
Sales	0.07M	P/B	1.07	EPS next Y	-	ROA	-74.99%	Short Interest	0.77M	Perf YTD	9.71%
Book/sh	0.35	P/C	0.97	EPS next 5Y	-	ROE	-99.94%	52W High	1.01 -63.07%	Perf Year	-25.99%
Cash/sh	0.39	P/FCF	-	EPS past 3/5Y	33.45% 26.52%	ROIC	-85.24%	52W Low	0.22 68.78%	Perf 3Y	-82.15%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.00% -	Gross Margin	-1244.34%	Volatility	12.10% 10.50%	Perf 5Y	-97.13%
Dividend TTM	-	EV/Sales	-2.85	EPS Y/Y TTM	56.28%	Oper. Margin	-6631.16%	ATR (14)	0.05	Perf 10Y	-99.25%
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	0.00%	Profit Margin	-6717.40%	RSI (14)	40.97	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	47.74%	SMA20	-13.86%	Beta	0.75	Target Price	10.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	0.00%	SMA50	-9.72%	Rel Volume	0.05	Prev Close	0.39
Employees	3	LT Debt/Eq	0.00	Earnings	-	SMA200	-21.90%	Avg Volume	4.89M	Price	0.37
IPO	May 13, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	252,232	Change	-3.79%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)